Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Kidney International Reports|September 18, 2024
Gene Expression Sets and Renal Profiling from the Renal AL Amyloid Involvement and NEOD00 (RAIN) TrialCindy Varga, Felix Eichinger, Viji Nair, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 5, 2025
Plasma Proteomic Profiles Among White and African American Individuals With Monoclonal Gammopathy of Unknown Significance (MGUS) and Multiple Myeloma (MM)Cindy Varga, Kip D Zimmerman, David M Foureau, et al.
Life (Basel, Switzerland)|March 28, 2024
Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study)Hamid Ehsan, Myra Robinson, Peter M Voorhees, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 16, 2023
Retrospective Review of Outcomes of Multiple Myeloma (MM) Patients With COVID-19 Infection (Two-Center Study)Hamid Ehsan, Alec Britt, Peter M Voorhees, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 10, 2017
Primary Amyloidosis With Renal Involvement: Outcomes in 77 Consecutive Patients at a Single CenterSandy W Wong, Denis Toskic, Melissa Warner, et al.
British Journal of Cancer Research|January 10, 2025
Seeking Amyloidosis Very Early: Free light Chain Differentials and IGLV Gene Use as Screening Variables for Light-chain Amyloidosis in λ Monoclonal GammopathiesPing Zhou, Mahesh M Mansukhani, Raymond Yeh, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 28, 2022
Standardizing Clinical Workflow for Assessing Minimal Residual Disease by Flow Cytometry in Multiple MyelomaDavid M Foureau, Barry A Paul, Fei Guo, et al.
Experimental Hematology & Oncology|October 26, 2018
Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growthXun Ma, Sandy W Wong, Ping Zhou, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 8, 2025
Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide (Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Real-World Experience at 2 InstitutesCindy Varga, Myra Robinson, Vikas Gupta, et al.
European Journal of Haematology|June 13, 2023
Bone marrow Ki-67 index is of prognostic value in newly diagnosed multiple myelomaShebli Atrash, Myra Robinson, Alankrita Taneja, et al.
Pageof 6